NUAK1 acts as a novel regulator of PD-L1 via activating GSK-3β/β-catenin pathway in hepatocellular carcinoma

Authors

Institutions

Publication Details

Journal
Molecular Medicine
Published
2025-02-03
DOI
https://doi.org/10.1186/s10020-025-01088-7
Citations
3
Primary Topic
Ubiquitin and proteasome pathways
Type
article
Field-Weighted Citation Impact
2.42
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

NUAK1 acts as a novel regulator of PD-L1 via activating GSK-3β/β-catenin pathway in hepatocellular carcinoma

Chunyu Hou, Chao‐Yan Yao, Xinrui Lv, Zhuangzhuang Liu et al.
3 citations
Molecular Medicine
Ubiquitin and proteasome pathways
2.42
article

NUAK1 acts as a novel regulator of PD-L1 via activating GSK-3β/β-catenin pathway in hepatocellular carcinoma

Chunyu Hou, Chao‐Yan Yao, Xinrui Lv, Zhuangzhuang Liu, Yuxin Fan, Feng-Yi Zhu, Xueli Liu, Dong Fang, Jinjin He, Ji-Qin Li, Hang-Tian Tao, Yu-Na Cheng, Cui-Qing Xie
article en
3 citations

Abstract

No abstract available for this paper.
Molecular MedicineVol. 31(1)
Henan University (CN), First Affiliated Hospital of Henan University (CN)
Good health and well-being
Openalex Percentile: Top 13%
Ubiquitin and proteasome pathways
2.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.